Crossmark

Development and Validation of RP-HPLC Method for Simultaneous Determination of Decitabine and Repaglinide: Application to Solid Lipid Nanoparticle Formulations with In Vitro Neurotoxicity Assessment

Crossref DOI link: https://doi.org/10.1007/s10337-025-04453-0

Published Online: 2025-11-16

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kumari, Shobha https://orcid.org/0000-0002-4069-7872
Gogikar, Shiva Kumar

Dikundwar, Amol G.

Dubey, Sunil Kumar https://orcid.org/0000-0002-7554-3232
Taliyan, Rajeev https://orcid.org/0000-0003-2147-2990
License Information

Text and Data Mining valid from 2025-11-16

Version of Record valid from 2025-11-16
More Information

Article History

Received: 13 August 2025

Revised: 31 October 2025

Accepted: 7 November 2025

First Online: 16 November 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below